Organizing Committee

John Mellors, Chair
University of Pittsburgh, USA

Douglas Richman, Co-chair
VA San Diego Healthcare System and
University of California San Diego, USA

Charles Boucher
Erasmus Medical Center Rotterdam
and University Hospital Utrecht,
the Netherlands

Brendan Larder
RDI, UK

Scientific Committee

Lee Bacheler
VircoLab, Inc, USA

Ralf Bartenschlager
University of Heidelberg, Germany

Nick Cammack
Roche Palo Alto, USA

François Clavel
Inserm U552, France

Bonaventura Clotet
Fundacio IRSI Caixa, Spain

John Coffin
National Cancer
Institute-Frederick, USA

Abel De La Rosa
Pharmasset, USA

Matthias Gotte
McGill University, Canada

Robert Grant
Gladstone/UCSF, USA

Michael Greenberg
Trimeris, Inc., USA

George Hanna
Bristol-Myers Squibb, USA

Richard Harrigan
BC Centre For Excellence in
HIV/AIDS, Canada

Daria Hazuda
Merck Research Labs, USA

Nicholas Hellmann
Kleiner Perkins Caufield & Byers

Walid Heneine
Centers for Disease Control
and Prevention, USA

Kurt Hertogs
Tibotec bvba, Belgium

Dale Kempf
Abbott, USA

Daniel Kuritzkes
Brigham and Women's Hospital, USA

Susan Little
University of California,
San Diego, USA

Stephen Locarnini
VIDRL, Australia

Douglas Mayers
Idenix Pharmaceuticals, USA

Michael Miller
Gilead Sciences, USA

Carlo Perno
Universita Di Tor Vergata, Italy

Christos Petropoulos
Monogram Biosciences, USA

Deenan Pillay
University College London, UK

Lisa Ross
GlaxoSmithKline, USA

Jonathan Schapiro
National Hemophilia Center - Israel,
Israel

Raymond Schinazi
Emory University/VA Medical Center,
USA

David Stammers
University of Oxford, UK

Mark Wainberg
McGill University AIDS Centre,
Canada

Mike Westby
Pfizer Global R&D, UK

Andrew Zolopa
Stanford University, USA